GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » 3-Year RORE %

HCmed Innovations Co (ROCO:6934) 3-Year RORE % : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. HCmed Innovations Co's 3-Year RORE % for the quarter that ended in Jun. 2024 was 0.00%.

The industry rank for HCmed Innovations Co's 3-Year RORE % or its related term are showing as below:

ROCO:6934's 3-Year RORE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -8.355
* Ranked among companies with meaningful 3-Year RORE % only.

HCmed Innovations Co 3-Year RORE % Historical Data

The historical data trend for HCmed Innovations Co's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCmed Innovations Co 3-Year RORE % Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23
3-Year RORE %
- - -

HCmed Innovations Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
3-Year RORE % Get a 7-Day Free Trial - - - - -

Competitive Comparison of HCmed Innovations Co's 3-Year RORE %

For the Medical Devices subindustry, HCmed Innovations Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co's 3-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's 3-Year RORE % falls into.



HCmed Innovations Co 3-Year RORE % Calculation

HCmed Innovations Co's 3-Year RORE % for the quarter that ended in Jun. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( - )/( -15.18-0 )
=/-15.18
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2024 and 3-year before.


HCmed Innovations Co  (ROCO:6934) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


HCmed Innovations Co 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of HCmed Innovations Co's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


HCmed Innovations Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product include Pulmogine and AdheResp.

HCmed Innovations Co Headlines

No Headlines